Antiplatelet Drugs Market to Hit USD 4.1 Bn by 2031 Due to the Increase in Prevalence…
<!-- Name:DistributionId Value:8791454 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Adenosine
Portage Biotech Hosting Key Opinion Leader Event on Targeting the Adenosine Pathway…
<!-- Name:DistributionId Value:8777609 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Nonalcoholic fatty liver disease progression: New study shows role of adenosine…
A study led by Texas A&M AgriLife Research provides compelling evidence of the important role of hepatocyte adenosine kinase in the progression of nonalcoholic fatty liver disease,…
Portage Biotech Bolsters Pipeline with Acquisition of Four Candidates Targeting the…
Acquires two clinical-stage, best in class adenosine compounds, and two preclinical assets for approximately $21 million upfront consideration Rob Glassman, M.D., Ph.D., director of…
Adial Pharmaceuticals Announces Research Collaboration with the Medical College of…
CHARLOTTESVILLE, Va., May 19, 2022 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), today announced that Purnovate, Inc., an Adial company…
Adial Announces Positive Pre-Clinical Data for its Adenosine Pain Platform
Data merits further testing for pain reduction as a possible alternative to opioids Validation of Purnovate acquisition CHARLOTTESVILLE, Va., July 14, 2021 (GLOBE NEWSWIRE) -- Adial…